ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,092Medicare Part D Prescriptions Filled, Including Refills

Rank: 290 out of 1844

$392K Total Retail Price of All Prescriptions

Rank: 549 out of 1844

250 Patients Receiving at Least One Drug in Part D
56%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 250 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

4% of this provider’s 5,340 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
FUROSEMIDE 384 251 1 7
LEVOTHYROXINE SODIUM 286 177 2 1
OMEPRAZOLE 220 103 3 5
SIMVASTATIN 219 118 4 3
MELOXICAM 212 120 5 28
CARISOPRODOL 205 34 R 6 128
LOVASTATIN 204 128 7 44
ISOSORBIDE MONONITRATE ER 200 168 8 59
PROMETHAZINE HCL 197 47 R 9 88
AMOXICILLIN 188 100 10 101
POTASSIUM CHLORIDE 185 137 11 16
ZOLPIDEM TARTRATE 183 106 12 23
METFORMIN HCL 181 121 13 8
TRAMADOL HCL 180 121 14 18
LISINOPRIL 179 101 15 4
LISINOPRIL-HYDROCHLOROTHIAZIDE 177 113 16 20
ALPRAZOLAM 174 90 17 124
CLOPIDOGREL 163 124 18 34
METOPROLOL TARTRATE 157 103 19 11
METOPROLOL SUCCINATE 154 106 20 14
AMLODIPINE BESYLATE 143 103 21 6
NEXIUM 132 67 22 31
GLYBURIDE 120 82 R 23 100
PRAVASTATIN SODIUM 118 57 24 10
CARVEDILOL 115 73 25 22
HYDROCHLOROTHIAZIDE 101 67 26 9
PLAVIX 98 78 27 61
CEPHALEXIN 97 52 28 56
EVISTA 94 47 29 95
CRESTOR 89 80 30 30
ATORVASTATIN CALCIUM 83 58 31 12
ATENOLOL 83 54 31 17
PROAIR HFA 78 38 33 45
RANITIDINE HCL 73 45 34 38
FAMOTIDINE 71 35 35 63
TAMSULOSIN HCL 67 54 36 27
PENTAZOCINE-NALOXONE HCL 66 22 R 10 37 405
KLOR-CON M20 65 27 38 54
THEOPHYLLINE ANHYDROUS 60 32 39 224
ENALAPRIL MALEATE 59 57 40 69
PANTOPRAZOLE SODIUM 58 24 41 32
PAROXETINE HCL 55 37 42 68
CAPTOPRIL 55 46 42 370
SPIRIVA 53 40 44 57
WARFARIN SODIUM 52 42 45 13
CYCLOBENZAPRINE HCL 51 18 R 46 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 7, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.